1. Home
  2. AUPH vs CMRE Comparison

AUPH vs CMRE Comparison

Compare AUPH & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.65

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$15.62

Market Cap

1.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
CMRE
Founded
1993
1974
Country
Canada
Monaco
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
AUPH
CMRE
Price
$16.65
$15.62
Analyst Decision
Buy
Hold
Analyst Count
4
1
Target Price
$17.25
$12.00
AVG Volume (30 Days)
1.2M
331.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
3.10%
EPS Growth
5075.00
N/A
EPS
0.53
N/A
Revenue
$283,055,000.00
N/A
Revenue This Year
$17.54
N/A
Revenue Next Year
$15.74
N/A
P/E Ratio
$32.58
$5.55
Revenue Growth
20.38
N/A
52 Week Low
$10.34
$10.84
52 Week High
$19.25
$18.06

Technical Indicators

Market Signals
Indicator
AUPH
CMRE
Relative Strength Index (RSI) 59.83 59.54
Support Level $14.67 $15.16
Resistance Level $19.25 $15.84
Average True Range (ATR) 0.58 0.45
MACD 0.20 0.09
Stochastic Oscillator 65.63 88.69

Price Performance

Historical Comparison
AUPH
CMRE

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: